vs
Side-by-side financial comparison of Ponce Financial Group, Inc. (PDLB) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
Ponce Financial Group, Inc. is the larger business by last-quarter revenue ($31.4M vs $20.6M, roughly 1.5× Entrada Therapeutics, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -84.4%, a 120.7% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs -65.2%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-39.7M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs 6.4%).
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
PDLB vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.4M | $20.6M |
| Net Profit | $10.1M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 43.6% | -106.0% |
| Net Margin | 36.3% | -84.4% |
| Revenue YoY | 37.6% | -65.2% |
| Net Profit YoY | 245.6% | -173.8% |
| EPS (diluted) | $0.43 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $31.4M | — | ||
| Q3 25 | $26.7M | — | ||
| Q2 25 | $26.5M | — | ||
| Q1 25 | $24.6M | $20.6M | ||
| Q4 24 | $22.8M | $37.4M | ||
| Q3 24 | $20.2M | $19.6M | ||
| Q2 24 | $20.2M | $94.7M | ||
| Q1 24 | $20.5M | $59.1M |
| Q4 25 | $10.1M | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $6.0M | $-17.3M | ||
| Q4 24 | $2.9M | $1.1M | ||
| Q3 24 | $2.4M | $-14.0M | ||
| Q2 24 | $3.2M | $55.0M | ||
| Q1 24 | $2.4M | $23.5M |
| Q4 25 | 43.6% | — | ||
| Q3 25 | 32.8% | — | ||
| Q2 25 | 30.2% | — | ||
| Q1 25 | 32.5% | -106.0% | ||
| Q4 24 | 19.6% | -15.7% | ||
| Q3 24 | 15.2% | -110.7% | ||
| Q2 24 | 21.8% | 56.4% | ||
| Q1 24 | 18.3% | 35.7% |
| Q4 25 | 36.3% | — | ||
| Q3 25 | 24.3% | — | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | 24.2% | -84.4% | ||
| Q4 24 | 14.1% | 3.0% | ||
| Q3 24 | 12.1% | -71.7% | ||
| Q2 24 | 15.8% | 58.1% | ||
| Q1 24 | 11.8% | 39.7% |
| Q4 25 | $0.43 | — | ||
| Q3 25 | $0.27 | — | ||
| Q2 25 | $0.25 | — | ||
| Q1 25 | $0.25 | $-0.42 | ||
| Q4 24 | $0.11 | $-0.20 | ||
| Q3 24 | $0.10 | $-0.35 | ||
| Q2 24 | $0.14 | $1.55 | ||
| Q1 24 | $0.11 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $126.2M | $67.8M |
| Total DebtLower is stronger | $596.1M | — |
| Stockholders' EquityBook value | $541.5M | $417.3M |
| Total Assets | $3.2B | $486.5M |
| Debt / EquityLower = less leverage | 1.10× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.2M | — | ||
| Q3 25 | $146.6M | — | ||
| Q2 25 | $126.6M | — | ||
| Q1 25 | $129.9M | $67.8M | ||
| Q4 24 | $139.8M | $101.2M | ||
| Q3 24 | $155.8M | $78.0M | ||
| Q2 24 | $103.2M | $185.3M | ||
| Q1 24 | $134.7M | $68.4M |
| Q4 25 | $596.1M | — | ||
| Q3 25 | $521.1M | — | ||
| Q2 25 | $536.1M | — | ||
| Q1 25 | $521.1M | — | ||
| Q4 24 | $596.1M | — | ||
| Q3 24 | $580.4M | — | ||
| Q2 24 | $680.4M | — | ||
| Q1 24 | $680.4M | — |
| Q4 25 | $541.5M | — | ||
| Q3 25 | $529.8M | — | ||
| Q2 25 | $521.1M | — | ||
| Q1 25 | $513.9M | $417.3M | ||
| Q4 24 | $505.5M | $428.7M | ||
| Q3 24 | $504.6M | $422.4M | ||
| Q2 24 | $497.7M | $429.9M | ||
| Q1 24 | $493.7M | $269.4M |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.2B | — | ||
| Q2 25 | $3.2B | — | ||
| Q1 25 | $3.1B | $486.5M | ||
| Q4 24 | $3.0B | $526.3M | ||
| Q3 24 | $3.0B | $554.6M | ||
| Q2 24 | $2.8B | $582.0M | ||
| Q1 24 | $2.8B | $510.8M |
| Q4 25 | 1.10× | — | ||
| Q3 25 | 0.98× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.01× | — | ||
| Q4 24 | 1.18× | — | ||
| Q3 24 | 1.15× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 1.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.6M | $-38.5M |
| Free Cash FlowOCF − Capex | $54.6M | $-39.7M |
| FCF MarginFCF / Revenue | 173.9% | -192.9% |
| Capex IntensityCapex / Revenue | 3.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 5.48× | — |
| TTM Free Cash FlowTrailing 4 quarters | $74.3M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.6M | — | ||
| Q3 25 | $1.4M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | $13.1M | $-38.5M | ||
| Q4 24 | $7.2M | $-31.6M | ||
| Q3 24 | $-14.6M | $-24.3M | ||
| Q2 24 | $-2.6M | $39.8M | ||
| Q1 24 | $1.5M | $-25.5M |
| Q4 25 | $54.6M | — | ||
| Q3 25 | $786.0K | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $12.9M | $-39.7M | ||
| Q4 24 | $4.5M | $-32.2M | ||
| Q3 24 | $-15.0M | $-24.9M | ||
| Q2 24 | $-2.6M | $38.8M | ||
| Q1 24 | $-315.0K | $-26.4M |
| Q4 25 | 173.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 22.4% | — | ||
| Q1 25 | 52.6% | -192.9% | ||
| Q4 24 | 19.7% | -86.2% | ||
| Q3 24 | -74.1% | -127.3% | ||
| Q2 24 | -13.0% | 41.0% | ||
| Q1 24 | -1.5% | -44.6% |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 2.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | 5.6% | ||
| Q4 24 | 11.9% | 1.7% | ||
| Q3 24 | 2.0% | 3.3% | ||
| Q2 24 | 0.3% | 1.1% | ||
| Q1 24 | 8.7% | 1.4% |
| Q4 25 | 5.48× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.01× | — | ||
| Q1 25 | 2.20× | — | ||
| Q4 24 | 2.46× | -27.94× | ||
| Q3 24 | -5.99× | — | ||
| Q2 24 | -0.80× | 0.72× | ||
| Q1 24 | 0.61× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
